Improving Lives After Lung Transplant Canvas Pharmaceuticals is developing Tacrolimus Inhalation Powder for prevention of acute rejection and maintenance of lung allograft in lung transplant patients to drive efficacy and decrease toxicities compared to standard of care oral tacrolimus. Tacrolimus Inhalation Powder is a novel, patented dry powder formulation of tacrolimus delivered via an easy-to-use dry powder…